[HTML] mdpi.com

[HTML][HTML] Immunotherapy for ALK-Rearranged Non-Small Cell Lung Cancer: Challenges Inform Promising Approaches

K Sankar, S Nagrath, N Ramnath - Cancers, 2021 - mdpi.com
Simple Summary Non-small cell lung cancer is the most common type of lung cancer.
Anaplastic Lymphoma Kinase (ALK) rearrangements have been found in 5–6% of non-small …
被引用次数：27 相关文章

Immunotherapy for ALK-Rearranged Non-Small Cell Lung Cancer: Challenges Inform Promising Approaches

K Sankar, S Nagrath, N Ramnath - Cancers, 2021 - pubmed.ncbi.nlm.nih.gov
Rearrangements in the Anaplastic Lymphoma Kinase (ALK) gene have been implicated in 5-
6% of all non-small cell lung cancers. ALK-rearranged non-small cell lung cancers are …

Immunotherapy for ALK-Rearranged Non-Small Cell Lung Cancer: Challenges Inform Promising Approaches.

K Sankar, S Nagrath, N Ramnath, R Chiarle - Cancers, 2021 - search.ebscohost.com
Abstract Simple Summary: Non-small cell lung cancer is the most common type of lung
cancer. Anaplastic Lymphoma Kinase (ALK) rearrangements have been found in 5–6% of …
[HTML] nih.gov

[HTML][HTML] Immunotherapy for ALK-Rearranged Non-Small Cell Lung Cancer: Challenges Inform Promising Approaches

K Sankar, S Nagrath, N Ramnath - Cancers, 2021 - ncbi.nlm.nih.gov
Abstract Rearrangements in the Anaplastic Lymphoma Kinase (ALK) gene have been
implicated in 5–6% of all non-small cell lung cancers. ALK-rearranged non-small cell lung …
[PDF] semanticscholar.org

[PDF][PDF] Immunotherapy for ALK-Rearranged Non-Small Cell Lung Cancer: Challenges Inform Promising Approaches. Cancers 2021, 13, 1476

K Sankar, S Nagrath, N Ramnath - 2021 - pdfs.semanticscholar.org
Rearrangements in the Anaplastic Lymphoma Kinase (ALK) gene have been implicated in 5–
6% of all non-small cell lung cancers. ALK-rearranged non-small cell lung cancers are …

Immunotherapy for ALK-Rearranged Non-Small Cell Lung Cancer: Challenges Inform Promising Approaches.

K Sankar, S Nagrath, N Ramnath - Cancers, 2021 - europepmc.org
Abstract Rearrangements in the Anaplastic Lymphoma Kinase (ALK) gene have been
implicated in 5–6% of all non-small cell lung cancers. ALK-rearranged non-small cell lung …

Immunotherapy for ALK-Rearranged Non-Small Cell Lung Cancer: Challenges Inform Promising Approaches.

K Sankar, S Nagrath, N Ramnath - Cancers, 2021 - europepmc.org
Rearrangements in the Anaplastic Lymphoma Kinase (ALK) gene have been implicated in 5-
6% of all non-small cell lung cancers. ALK-rearranged non-small cell lung cancers are …